Zuowei Zhao

1.2k total citations
55 papers, 923 citations indexed

About

Zuowei Zhao is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Zuowei Zhao has authored 55 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Zuowei Zhao's work include Cancer Cells and Metastasis (12 papers), Cancer Genomics and Diagnostics (7 papers) and MRI in cancer diagnosis (4 papers). Zuowei Zhao is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Cancer Genomics and Diagnostics (7 papers) and MRI in cancer diagnosis (4 papers). Zuowei Zhao collaborates with scholars based in China, United States and Japan. Zuowei Zhao's co-authors include Caigang Liu, Hao Zhang, Ping Lu, Xuelu Li, Man Li, Xin Zhang, Ningning Gao, Xiaofei Wei, Huanming Xu and Dan Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Medical Physics.

In The Last Decade

Zuowei Zhao

51 papers receiving 913 citations

Peers

Zuowei Zhao
Kai Doberstein Germany
Ke Sai China
Robert Cornelison United States
Wenjun Yi China
Vera Levina United States
Stefanie Tiede Switzerland
Anna M. Chiarella United States
Kideok Jin United States
Qianshan Ding China
Simon A. Williams United States
Kai Doberstein Germany
Zuowei Zhao
Citations per year, relative to Zuowei Zhao Zuowei Zhao (= 1×) peers Kai Doberstein

Countries citing papers authored by Zuowei Zhao

Since Specialization
Citations

This map shows the geographic impact of Zuowei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuowei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuowei Zhao more than expected).

Fields of papers citing papers by Zuowei Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuowei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuowei Zhao. The network helps show where Zuowei Zhao may publish in the future.

Co-authorship network of co-authors of Zuowei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Zuowei Zhao. A scholar is included among the top collaborators of Zuowei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuowei Zhao. Zuowei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Ye, Huixin Liu, Meiling Wang, et al.. (2024). The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019. International Journal of Public Health. 69. 1607352–1607352.
2.
Wang, Meiling, Bo Pan, Lu Hou, et al.. (2024). STIL facilitates the development and malignant progression of triple-negative breast cancer through activation of Fanconi anemia pathway via interacting with KLF16. Translational Oncology. 46. 102010–102010. 2 indexed citations
3.
Bai, Xue, et al.. (2024). Organoids as a model system for researching human neuroendocrine tumor of the breast. Cancer Cell International. 24(1). 433–433.
4.
Chen, Fengxi, Xueqing Wang, Meiling Wang, et al.. (2024). mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation. Frontiers in Oncology. 14. 1312634–1312634. 4 indexed citations
5.
Zhao, Xiaotian, Jingwen Liu, Yang Xu, et al.. (2022). Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer. Molecular Oncology. 16(20). 3689–3702. 5 indexed citations
6.
Wang, Meiling, et al.. (2022). The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer. Breast Cancer Targets and Therapy. Volume 14. 291–309. 20 indexed citations
7.
8.
9.
Pan, Bo, Yaqian Liu, Na Li, et al.. (2020). Establishment and characterization of breast cancer organoids from a patient with mammary Paget’s disease. Cancer Cell International. 20(1). 365–365. 16 indexed citations
10.
Wang, Jinke, et al.. (2020). A comprehensive hierarchical classification based on multi-features of breast DCE-MRI for cancer diagnosis. Medical & Biological Engineering & Computing. 58(10). 2413–2425. 5 indexed citations
11.
Li, Xuelu, et al.. (2019). Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer. Cancer Biomarkers. 25(1). 19–27. 9 indexed citations
12.
Li, Xuelu, et al.. (2017). High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer. Cellular Physiology and Biochemistry. 43(2). 531–539. 32 indexed citations
13.
Gao, Yan, Xianzhong Yu, Yanbing Li, et al.. (2016). Changes in methylation of genomic DNA from chicken immune organs in response to H5N1 influenza virus infection. Genetics and Molecular Research. 15(3). 12 indexed citations
14.
Zhang, Hao, Minna Luo, Zining Jin, et al.. (2015). Expression and clinicopathological significance of FSIP1 in breast cancer. Oncotarget. 6(12). 10658–10666. 21 indexed citations
15.
Wang, Dan, Ping Lu, Hao Zhang, et al.. (2014). Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients. Oncotarget. 5(21). 10803–10815. 136 indexed citations
16.
Liu, Yiping, et al.. (2014). A new background distribution‐based active contour model for three‐dimensional lesion segmentation in breast DCE‐MRI. Medical Physics. 41(8Part1). 82303–82303. 14 indexed citations
17.
Xu, Huanming, Caigang Liu, Zuowei Zhao, et al.. (2013). Clinical implications of GRHL3 protein expression in breast cancer. Tumor Biology. 35(3). 1827–1831. 17 indexed citations
18.
Liu, Caigang, Yang Luo, Xing Liu, Ping Lu, & Zuowei Zhao. (2012). Clinical Implications of CD44+/CD24− Tumor Cell Ratio in Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 27(5). 324–328. 13 indexed citations
19.
Li, Man & Zuowei Zhao. (2012). Clinical implications of EphB4 receptor expression in pancreatic cancer. Molecular Biology Reports. 40(2). 1735–1741. 9 indexed citations
20.
Dai, Li, Yanmei Zhao, Runze Zhao, et al.. (2011). Molecular cloning and sequence analysis of follicle-stimulating hormone beta polypeptide precursor cDNA from the bovine pituitary gland. Genetics and Molecular Research. 10(3). 1504–1513. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Doberstein Breakdown of academic impact, for papers by Ke Sai Breakdown of academic impact, for papers by Robert Cornelison Breakdown of academic impact, for papers by Wenjun Yi Breakdown of academic impact, for papers by Vera Levina Breakdown of academic impact, for papers by Stefanie Tiede Breakdown of academic impact, for papers by Anna M. Chiarella Breakdown of academic impact, for papers by Kideok Jin Breakdown of academic impact, for papers by Qianshan Ding Breakdown of academic impact, for papers by Simon A. Williams
Rankless by CCL
2026